214 related articles for article (PubMed ID: 33190170)
1. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1.
Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
[TBL] [Abstract][Full Text] [Related]
3. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
4. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
6. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
7. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
8. NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.
Fan Z; Zheng J; Xue Y; Liu X; Wang D; Yang C; Ma J; Liu L; Ruan X; Wang Z; Liu Y
Cell Death Dis; 2018 Dec; 9(12):1165. PubMed ID: 30518750
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
[TBL] [Abstract][Full Text] [Related]
10. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of BCL6 Inhibited Malignant Phenotype and Enhanced Sensitivity of Glioblastoma Cells to TMZ through AKT Pathway.
Song W; Wang Z; Kan P; Ma Z; Wang Y; Wu Q; Yao X; Zhang B
Biomed Res Int; 2018; 2018():6953506. PubMed ID: 30420967
[TBL] [Abstract][Full Text] [Related]
12. GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
Xiao Z; Yang X; Liu Z; Shao Z; Song C; Zhang K; Wang X; Li Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649841
[TBL] [Abstract][Full Text] [Related]
13. NCAPG2 facilitates glioblastoma cells' malignancy and xenograft tumor growth via HBO1 activation by phosphorylation.
Wu J; Li L; Jiang G; Zhan H; Zhu X; Yang W
Cell Tissue Res; 2021 Feb; 383(2):693-706. PubMed ID: 32897418
[TBL] [Abstract][Full Text] [Related]
14. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
15. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
16. SOX3 can promote the malignant behavior of glioblastoma cells.
Marjanovic Vicentic J; Drakulic D; Garcia I; Vukovic V; Aldaz P; Puskas N; Nikolic I; Tasic G; Raicevic S; Garros-Regulez L; Sampron N; Atkinson MJ; Anastasov N; Matheu A; Stevanovic M
Cell Oncol (Dordr); 2019 Feb; 42(1):41-54. PubMed ID: 30209685
[TBL] [Abstract][Full Text] [Related]
17. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
Huang S; Qi P; Zhang T; Li F; He X
Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
[TBL] [Abstract][Full Text] [Related]
18. RNaseH2A is involved in human gliomagenesis through the regulation of cell proliferation and apoptosis.
Dai B; Zhang P; Zhang Y; Pan C; Meng G; Xiao X; Wu Z; Jia W; Zhang J; Zhang L
Oncol Rep; 2016 Jul; 36(1):173-80. PubMed ID: 27176716
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1.
Liu S; Yin F; Fan W; Wang S; Guo XR; Zhang JN; Tian ZM; Fan M
J Exp Clin Cancer Res; 2012 May; 31(1):52. PubMed ID: 22650359
[TBL] [Abstract][Full Text] [Related]
20. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]